,reactionmeddraversionpt,reactionmeddrapt,safetyreportid,reactionoutcome
0,22.0,Product substitution issue,16378687,
1,22.0,Alopecia,16378687,
0,22.0,Death,16378706,
0,22.0,Flatulence,16378724,
0,22.0,Weight increased,16378799,
0,22.0,Pneumonia,16379133,
0,22.0,Hot flush,16379150,
0,22.0,Headache,16379182,
1,22.0,Bone pain,16379182,
0,22.0,Osteonecrosis,16379214,
0,22.0,Head injury,16379490,
1,22.0,Atrial fibrillation,16379490,
2,22.0,Fall,16379490,
3,22.0,Blood electrolytes abnormal,16379490,
4,22.0,Thrombosis,16379490,
5,22.0,Duodenal ulcer haemorrhage,16379490,
6,22.0,Hand fracture,16379490,
0,22.0,Death,16379522,
0,22.0,Disease progression,16379534,
0,22.0,Death,16379541,
0,22.0,Diarrhoea,16379585,
0,22.0,Death,16379602,
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,16379665,
0,22.0,Headache,16379672,
1,22.0,Hypertension,16379672,
2,22.0,Neck pain,16379672,
3,22.0,Hot flush,16379672,
0,22.0,Atrioventricular block first degree,16382057,
1,22.0,Presyncope,16382057,
2,22.0,Cough,16382057,
3,22.0,Bundle branch block left,16382057,
4,22.0,Rhinorrhoea,16382057,
5,22.0,Aortic valve replacement,16382057,
0,22.0,Cystitis,16382172,
1,22.0,Pneumonia,16382172,
0,22.0,Death,16382585,
0,22.0,Therapy cessation,16382599,
1,22.0,Neutropenia,16382599,
0,22.0,Rectal haemorrhage,16382648,
1,22.0,Syncope,16382648,
2,22.0,Therapy cessation,16382648,
0,22.0,Pulmonary thrombosis,16382863,
0,22.0,Loss of consciousness,16383087,
1,22.0,Fall,16383087,
2,22.0,Therapy cessation,16383087,
3,22.0,Wrist fracture,16383087,
0,22.0,Neutrophil count decreased,16383526,
1,22.0,Fatigue,16383526,
0,22.0,Vertigo,16383593,
0,22.0,Pain in extremity,16383600,
1,22.0,Foot fracture,16383600,
0,22.0,Pain of skin,16383734,
0,22.0,Decreased appetite,16383995,
1,22.0,Heart rate decreased,16383995,
2,22.0,Arthralgia,16383995,
3,22.0,Tachycardia,16383995,
4,22.0,Nausea,16383995,
5,22.0,Dehydration,16383995,
6,22.0,Headache,16383995,
7,22.0,Hypokalaemia,16383995,
8,22.0,Dizziness,16383995,
9,22.0,Muscular weakness,16383995,
0,22.0,Full blood count decreased,16384005,
0,22.0,Fatigue,16384076,
1,22.0,Arthralgia,16384076,
2,22.0,Red blood cell count increased,16384076,
3,22.0,Platelet count increased,16384076,
4,22.0,Prostatic specific antigen abnormal,16384076,
0,22.0,Off label use,16384131,
0,22.0,Full blood count decreased,16384136,
0,22.0,Paraesthesia,16384137,
1,22.0,Feeling cold,16384137,
0,22.0,Pain of skin,16384443,
0,22.0,Diarrhoea,16384444,
0,22.0,Cerebral disorder,16384447,
1,22.0,Musculoskeletal stiffness,16384447,
0,22.0,Chest pain,16384776,
1,22.0,Dyspnoea,16384776,
2,22.0,Pneumonitis,16384776,
3,22.0,Toxicity to various agents,16384776,
4,22.0,Microvascular coronary artery disease,16384776,
5,22.0,Hypokinesia,16384776,
6,22.0,Hypertensive heart disease,16384776,
7,22.0,Rectal haemorrhage,16384776,
8,22.0,Dyspnoea exertional,16384776,
9,22.0,Heart rate decreased,16384776,
10,22.0,Cough,16384776,
0,22.0,Blood potassium decreased,16385650,
1,22.0,Gastroenteritis viral,16385650,
0,22.0,Dystonia,16387132,
1,22.0,Respiratory distress,16387132,
0,22.0,Prostatic specific antigen increased,16388167,
0,22.0,Gastrointestinal anastomotic complication,16388219,
1,22.0,Anal incontinence,16388219,
2,22.0,Diarrhoea,16388219,
0,22.0,Pneumonia,16388545,
1,22.0,Therapy cessation,16388545,
2,22.0,Sepsis,16388545,
0,22.0,Hip surgery,16388555,
0,22.0,Nausea,16388603,
0,22.0,Death,16388848,
0,22.0,Arthritis,16388855,
0,22.0,Dehydration,16389178,
1,22.0,Colitis ulcerative,16389178,
0,22.0,Chest pain,16389245,
0,22.0,Tenderness,16390437,
1,22.0,Infusion related reaction,16390437,
0,22.0,Large intestine infection,16392731,
1,22.0,Large intestinal obstruction,16392731,
0,22.0,Acne,16392812,
1,22.0,Hyperhidrosis,16392812,
2,22.0,Decreased appetite,16392812,
0,22.0,Hypoaesthesia oral,16392879,
1,22.0,Erythema,16392879,
2,22.0,Urticaria,16392879,
3,22.0,Paraesthesia oral,16392879,
0,22.0,White blood cell count decreased,16393009,
0,22.0,Sunburn,16393294,
0,22.0,Blood count abnormal,16393481,
0,22.0,Rash,16393521,
1,22.0,Feeling abnormal,16393521,
0,22.0,Full blood count decreased,16393579,
0,22.0,Unevaluable event,16393710,
0,22.0,Onychoclasis,16393716,
1,22.0,Hypoaesthesia,16393716,
2,22.0,Pain in extremity,16393716,
0,22.0,Dyspnoea,16393724,
1,22.0,Pulmonary thrombosis,16393724,
0,22.0,Malaise,16393735,
0,22.0,Pruritus,16393750,
0,22.0,Off label use,16394063,
0,22.0,Off label use,16395130,
0,22.0,Off label use,16395152,
0,22.0,Pulmonary embolism,16395547,
1,22.0,Peripheral embolism,16395547,
0,22.0,Nausea,16258819,1
1,22.0,Hypertension,16258819,1
2,22.0,Back pain,16258819,1
3,22.0,Infusion related reaction,16258819,1
4,22.0,Headache,16258819,1
5,22.0,Dyspnoea,16258819,1
0,22.0,Asthenia,16258824,6
1,22.0,Altered state of consciousness,16258824,6
2,22.0,Dyspnoea,16258824,6
3,22.0,Pulse absent,16258824,6
0,22.0,Embolism,16258825,2
0,22.0,Pulmonary embolism,16258849,5
1,22.0,Embolism venous,16258849,6
2,22.0,Drug interaction,16258849,5
3,22.0,Somnolence,16258849,3
4,22.0,Disturbance in attention,16258849,6
5,22.0,Confusional state,16258849,3
0,22.0,Hypokalaemia,16258867,1
1,22.0,Nausea,16258867,1
2,22.0,Vomiting,16258867,1
3,22.0,Diarrhoea,16258867,6
0,22.0,General physical health deterioration,16258910,6
1,22.0,Thrombocytopenia,16258910,6
2,22.0,Malignant neoplasm progression,16258910,5
3,22.0,Leukopenia,16258910,6
4,22.0,Anaemia,16258910,6
0,22.0,Depressed level of consciousness,16258912,1
0,22.0,Paralysis recurrent laryngeal nerve,16259057,1
0,22.0,Hypersensitivity,16259094,1
1,22.0,Dyspepsia,16259094,1
0,22.0,Febrile neutropenia,16259096,1
0,22.0,Sepsis,16259196,6
1,22.0,Multiple organ dysfunction syndrome,16259196,5
2,22.0,Myocarditis,16259196,3
0,22.0,Immune-mediated enterocolitis,16259198,3
0,22.0,Renal failure,16259227,3
0,22.0,Colitis ischaemic,16259251,3
0,22.0,Hepatic function abnormal,16259252,3
0,22.0,Throat irritation,16259264,1
0,22.1,Headache,16259271,2
1,22.1,Acute kidney injury,16259271,6
2,22.1,Peripheral motor neuropathy,16259271,3
3,22.1,Hypertensive urgency,16259271,2
4,22.1,Cardiac failure,16259271,6
0,22.0,Transient ischaemic attack,16259275,1
0,22.0,Abdominal pain upper,16259284,1
1,22.0,Fatigue,16259284,6
2,22.0,Vomiting,16259284,1
3,22.0,Diarrhoea,16259284,6
4,22.0,Nausea,16259284,6
0,22.0,Lip pruritus,16259355,1
1,22.0,Pruritus,16259355,1
2,22.0,Palmar erythema,16259355,1
0,22.0,Paraesthesia,16259371,1
1,22.0,Body temperature increased,16259371,1
2,22.0,Chills,16259371,1
0,22.0,Pneumonia,16259372,1
1,22.0,Febrile neutropenia,16259372,1
0,22.0,Hypertensive crisis,16259373,1
1,22.0,Cholangitis,16259373,6
2,22.0,Diarrhoea,16259373,2
3,22.0,Sepsis,16259373,5
4,22.0,Subclavian vein thrombosis,16259373,2
5,22.0,Humerus fracture,16259373,2
0,22.0,Polyneuropathy,16259374,3
1,22.0,Sensory disturbance,16259374,3
2,22.0,Neuralgia,16259374,6
3,22.0,Sleep disorder,16259374,3
4,22.0,Neurotoxicity,16259374,3
5,22.0,Dizziness,16259374,6
6,22.0,Tinnitus,16259374,6
0,22.0,Thrombocytopenia,16259375,1
1,22.0,Bicytopenia,16259375,1
0,22.0,Febrile neutropenia,16259485,2
1,22.0,Dehydration,16259485,2
2,22.0,Gastric ulcer,16259485,6
3,22.0,Syncope,16259485,1
4,22.0,Aortitis,16259485,1
5,22.0,Diarrhoea,16259485,2
0,22.0,Pruritus,16259486,6
1,22.0,Neutropenia,16259486,1
2,22.0,Nausea,16259486,6
3,22.0,Off label use,16259486,6
4,22.0,Polyneuropathy,16259486,6
0,22.0,Death,16259491,5
0,22.0,Abdominal pain,16259503,6
1,22.0,Aortitis,16259503,1
0,22.0,Haemorrhage,16259516,6
0,22.0,Drug ineffective,16259521,3
1,22.0,Death,16259521,5
2,22.0,Cardiac failure congestive,16259521,3
0,22.0,Gastrointestinal disorder,16259542,1
0,22.0,Thrombocytopenia,16259663,6
1,22.0,Rash,16259663,6
2,22.0,Alopecia,16259663,6
3,22.0,Arthralgia,16259663,6
4,22.0,Alanine aminotransferase increased,16259663,6
5,22.0,Stomatitis,16259663,6
6,22.0,Product use issue,16259663,6
7,22.0,Decreased appetite,16259663,6
8,22.0,Off label use,16259663,6
9,22.0,Febrile neutropenia,16259663,6
10,22.0,Neuropathy peripheral,16259663,6
11,22.0,Hypertension,16259663,6
12,22.0,Fatigue,16259663,6
13,22.0,Neutropenia,16259663,6
14,22.0,Nausea,16259663,6
15,22.0,Pyrexia,16259663,6
16,22.0,Diarrhoea,16259663,6
17,22.0,Leukopenia,16259663,6
18,22.0,Anaemia,16259663,6
19,22.0,Constipation,16259663,6
20,22.0,Aspartate aminotransferase increased,16259663,6
21,22.0,Myalgia,16259663,6
0,22.0,Neutropenia,16259665,6
1,22.0,Anaemia,16259665,6
2,22.0,Febrile neutropenia,16259665,6
3,22.0,Cough,16259665,6
4,22.0,Dizziness,16259665,6
5,22.0,Transaminases increased,16259665,6
6,22.0,Vomiting,16259665,6
7,22.0,Mucosal inflammation,16259665,6
8,22.0,Dyspepsia,16259665,6
9,22.0,Insomnia,16259665,6
10,22.0,Stomatitis,16259665,6
11,22.0,Myalgia,16259665,6
12,22.0,Lymphopenia,16259665,6
13,22.0,Bone pain,16259665,6
14,22.0,Constipation,16259665,6
15,22.0,Thrombocytopenia,16259665,6
16,22.0,Pneumonia,16259665,6
17,22.0,Alopecia,16259665,6
18,22.0,Nausea,16259665,6
19,22.0,Infection,16259665,6
20,22.0,Decreased appetite,16259665,6
21,22.0,Wound infection,16259665,6
22,22.0,Asthenia,16259665,6
23,22.0,Pain,16259665,6
24,22.0,Diarrhoea,16259665,6
0,22.0,Malignant neoplasm progression,16259741,5
0,22.0,Pneumonia,16259805,6
1,22.0,Gait inability,16259805,6
2,22.0,Product dose omission,16259805,6
3,22.0,Cardiac failure,16259805,6
4,22.0,Respiratory failure,16259805,5
5,22.0,Chronic obstructive pulmonary disease,16259805,5
6,22.0,Pneumonia,16259805,6
7,22.0,Agitation,16259805,6
0,22.1,Nausea,16259814,3
1,22.1,Malignant neoplasm progression,16259814,5
2,22.1,Epilepsy,16259814,3
3,22.1,Anaemia,16259814,1
4,22.1,Metastases to meninges,16259814,3
0,22.0,Tumour haemorrhage,16259876,5
1,22.0,Ileal perforation,16259876,3
0,22.0,Hyperuricaemia,16259934,2
1,22.0,Contraindicated product administered,16259934,6
0,22.0,Breast cancer metastatic,16260010,6
1,22.0,Death,16260010,5
2,22.0,Off label use,16260010,6
3,22.0,Diarrhoea,16260010,6
0,22.0,Drug resistance,16260040,6
0,22.0,Neuropathy peripheral,16260083,2
1,22.0,Off label use,16260083,
2,22.0,Exercise tolerance decreased,16260083,2
3,22.0,Chest X-ray abnormal,16260083,
4,22.0,Fatigue,16260083,2
5,22.0,Blood pressure increased,16260083,
0,22.0,Hair disorder,16260103,3
1,22.0,Hair colour changes,16260103,3
2,22.0,Madarosis,16260103,3
3,22.0,Alopecia,16260103,3
4,22.0,Hair texture abnormal,16260103,3
0,22.1,Hair texture abnormal,16260108,3
1,22.1,Hair disorder,16260108,3
2,22.1,Hair colour changes,16260108,3
3,22.1,Alopecia,16260108,3
0,22.0,Alopecia,16260118,3
0,22.0,Encephalopathy,16260149,5
1,22.0,Hepatic cirrhosis,16260149,5
0,22.1,Blood count abnormal,16260182,2
0,22.0,Alopecia,16260194,6
1,22.0,Fatigue,16260194,6
2,22.0,Dizziness,16260194,6
3,22.0,Leukopenia,16260194,6
4,22.0,Diarrhoea,16260194,6
5,22.0,Arthralgia,16260194,6
0,22.1,Inappropriate schedule of product administration,16260205,6
1,22.1,Death,16260205,5
0,22.0,Malignant neoplasm progression,16260215,6
1,22.0,Pericardial effusion,16260215,6
2,22.0,Pleural effusion,16260215,6
0,22.0,Alopecia,16260223,3
1,22.0,Hair disorder,16260223,3
2,22.0,Madarosis,16260223,3
3,22.0,Hair colour changes,16260223,3
4,22.0,Hair texture abnormal,16260223,3
0,22.0,Skin lesion,16260289,6
1,22.0,Nausea,16260289,6
2,22.0,Diarrhoea,16260289,6
3,22.0,Weight increased,16260289,6
4,22.0,Rash,16260289,6
5,22.0,Swelling face,16260289,6
6,22.0,Neoplasm progression,16260289,6
0,22.1,Nasopharyngitis,16260309,3
1,22.1,Cardiac failure congestive,16260309,3
2,22.1,Weight decreased,16260309,3
3,22.1,Cardiovascular disorder,16260309,3
4,22.1,Wound,16260309,3
5,22.1,Pneumonia,16260309,6
6,22.1,Cellulitis,16260309,6
7,22.1,Diarrhoea,16260309,3
8,22.1,Anaemia,16260309,3
9,22.1,Dyspnoea,16260309,3
10,22.1,Fluid retention,16260309,3
0,22.0,Neutrophil count decreased,16260330,1
1,22.0,Bone marrow failure,16260330,6
0,22.1,Hypoacusis,16260348,6
1,22.1,Pulmonary oedema,16260348,6
2,22.1,Memory impairment,16260348,6
3,22.1,Fatigue,16260348,6
0,22.0,Death,16260370,5
0,22.1,Stomatitis,16260383,3
1,22.1,Palmar-plantar erythrodysaesthesia syndrome,16260383,1
2,22.1,Muscular weakness,16260383,1
3,22.1,Nausea,16260383,1
4,22.1,Constipation,16260383,3
5,22.1,Peripheral sensory neuropathy,16260383,3
6,22.1,Urinary tract infection,16260383,1
7,22.1,Vomiting,16260383,1
8,22.1,Nausea,16260383,1
0,22.0,Metastases to liver,16260385,6
1,22.0,Malignant neoplasm progression,16260385,6
2,22.0,Appendicitis,16260385,6
3,22.0,Breast cancer,16260385,6
4,22.0,Metastases to lymph nodes,16260385,6
0,22.0,Abdominal distension,16260387,1
1,22.0,Diarrhoea,16260387,1
0,22.0,Congestive cardiomyopathy,16260464,3
0,22.0,Neutropenia,16260465,6
0,22.0,Carbohydrate antigen 125 increased,16260466,1
1,22.0,Brain neoplasm,16260466,1
0,22.1,Cryptococcosis,16260559,6
1,22.1,Cardiac failure acute,16260559,5
2,22.1,Lung disorder,16260559,5
3,22.1,Interstitial lung disease,16260559,6
0,22.0,Depression,16260568,6
1,22.0,Hair texture abnormal,16260568,3
2,22.0,Madarosis,16260568,3
3,22.0,Hair disorder,16260568,3
4,22.0,Hair colour changes,16260568,3
5,22.0,Alopecia,16260568,3
0,22.0,Hypercreatinaemia,16260593,6
1,22.0,Asthenia,16260593,6
2,22.0,Hypertension,16260593,6
0,22.0,Cardiomyopathy,16260605,6
1,22.0,Incorrect dosage administered,16260605,6
0,22.0,Electrocardiogram ST segment elevation,16260613,6
0,22.1,Interstitial lung disease,16260617,1
0,22.0,Cardiotoxicity,16260629,6
0,22.0,Headache,16260703,6
0,22.0,Neoplasm malignant,16260705,6
1,22.0,Tumour marker increased,16260705,6
2,22.0,Hypertension,16260705,3
3,22.0,Muscular weakness,16260705,6
4,22.0,Sinusitis,16260705,6
5,22.0,Dyspnoea,16260705,2
6,22.0,Cough,16260705,6
7,22.0,Weight decreased,16260705,6
8,22.0,Pyrexia,16260705,2
9,22.0,Malignant neoplasm progression,16260705,5
10,22.0,Asthenia,16260705,3
11,22.0,Dehydration,16260705,6
12,22.0,Renal function test abnormal,16260705,3
13,22.0,Thrombosis,16260705,6
14,22.0,Urinary tract infection,16260705,1
15,22.0,Clostridium difficile colitis,16260705,6
16,22.0,Nephropathy,16260705,6
17,22.0,Pneumonia,16260705,6
18,22.0,Pleural effusion,16260705,1
19,22.0,Fatigue,16260705,3
20,22.0,Chills,16260705,1
0,22.0,Headache,16260725,6
0,22.0,Colitis,16260750,2
0,22.1,Chills,16260775,1
1,22.1,Erythema,16260775,1
2,22.1,Dyspnoea,16260775,1
3,22.1,Oxygen saturation decreased,16260775,1
0,22.0,Headache,16260793,6
0,22.0,Headache,16260804,6
0,22.0,Cardiotoxicity,16260815,2
1,22.0,Left ventricular dysfunction,16260815,2
2,22.0,Cardiomyopathy,16260815,2
3,22.0,Cardiac failure,16260815,2
0,22.0,Atrial fibrillation,16260844,1
0,22.0,Death,16260849,5
1,22.0,Product use issue,16260849,6
0,22.0,Acute myocardial infarction,16260853,6
0,22.0,Neutropenia,16260855,1
0,22.0,Therapeutic response decreased,16260902,6
1,22.0,Prostatic specific antigen increased,16260902,6
0,22.0,Neutrophil count decreased,16260910,6
0,22.0,Neutrophil count decreased,16260912,6
0,22.0,Neutrophil count decreased,16260913,6
0,22.0,Neutrophil count decreased,16260914,6
0,22.0,Malaise,16260929,2
1,22.0,Diarrhoea,16260929,6
2,22.0,Nausea,16260929,6
3,22.0,Acute kidney injury,16260929,2
4,22.0,Dehydration,16260929,6
5,22.0,Decreased appetite,16260929,2
6,22.0,Haemorrhagic diathesis,16260929,6
7,22.0,Drug interaction,16260929,6
8,22.0,Urine output decreased,16260929,2
0,22.0,Insomnia,16260935,1
1,22.0,Dry mouth,16260935,3
2,22.0,Product packaging difficult to open,16260935,3
3,22.0,Abdominal discomfort,16260935,3
4,22.0,Malaise,16260935,3
5,22.0,Asthenia,16260935,3
6,22.0,Vomiting,16260935,3
7,22.0,Hypersomnia,16260935,3
0,22.0,Cerebrovascular accident,16260943,5
0,22.0,Pneumonia,16260945,1
0,22.0,Urinary tract infection,16260946,6
0,22.0,Bone pain,16261208,6
1,22.0,Musculoskeletal chest pain,16261208,6
2,22.0,Metastases to bone,16261208,6
3,22.0,Breast cancer recurrent,16261208,6
0,22.0,Death,16261210,5
0,22.1,Osteoporosis,16261212,3
1,22.1,Spinal compression fracture,16261212,1
0,22.0,Headache,16261217,6
0,22.0,Headache,16261237,6
0,22.0,Headache,16261265,6
0,22.0,Intestinal obstruction,16261266,6
1,22.0,Cardiac disorder,16261266,6
2,22.0,Vomiting,16261266,6
3,22.0,Anaemia,16261266,6
4,22.0,Dehydration,16261266,6
5,22.0,Abdominal pain upper,16261266,6
6,22.0,Renal function test abnormal,16261266,6
7,22.0,Small intestinal obstruction,16261266,6
8,22.0,Drug intolerance,16261266,6
0,22.0,Bicytopenia,16261279,1
1,22.0,Thrombocytopenia,16261279,3
2,22.0,Alopecia,16261279,3
0,22.0,Headache,16261280,6
0,22.0,Vomiting,16261293,6
1,22.0,Nausea,16261293,6
2,22.0,Death,16261293,5
0,22.0,Bloody discharge,16261296,3
0,22.0,Pallor,16261323,1
1,22.0,Loss of consciousness,16261323,1
2,22.0,Shock,16261323,1
3,22.0,Hyperhidrosis,16261323,1
4,22.0,Dyspnoea,16261323,1
5,22.0,Blood pressure immeasurable,16261323,1
0,22.0,Headache,16261326,6
0,22.0,Headache,16261328,6
0,22.0,Headache,16261329,6
0,22.0,Headache,16261382,6
0,22.0,Headache,16261386,6
0,22.0,Headache,16261392,6
0,22.0,General physical health deterioration,16261396,2
0,22.0,Dermatitis exfoliative generalised,16261397,1
0,22.0,Headache,16261403,6
0,22.0,Headache,16261423,6
0,22.0,Breast cancer metastatic,16261437,1
1,22.0,Dysgeusia,16261437,3
2,22.0,Oropharyngeal pain,16261437,1
3,22.0,Malignant neoplasm progression,16261437,1
4,22.0,Decreased appetite,16261437,3
5,22.0,Nausea,16261437,1
6,22.0,Fatigue,16261437,3
7,22.0,Abdominal discomfort,16261437,3
8,22.0,Pruritus,16261437,1
9,22.0,Dyspnoea,16261437,3
10,22.0,Vomiting,16261437,1
11,22.0,Hot flush,16261437,1
12,22.0,Cough,16261437,3
0,22.0,Neoplasm progression,16261471,5
0,22.0,Headache,16261482,6
0,22.0,Headache,16261483,6
0,22.0,Headache,16261487,6
0,22.0,Headache,16261490,6
0,22.0,Alopecia,16261495,2
1,22.0,Psychological trauma,16261495,6
2,22.0,Emotional distress,16261495,6
3,22.0,Pain,16261495,6
4,22.0,Impaired quality of life,16261495,6
5,22.0,Anxiety,16261495,6
0,22.0,Anxiety,16261501,6
1,22.0,Emotional distress,16261501,6
2,22.0,Pain,16261501,6
3,22.0,Psychological trauma,16261501,6
4,22.0,Alopecia,16261501,2
5,22.0,Impaired quality of life,16261501,6
0,22.0,Anxiety,16261503,6
1,22.0,Pain,16261503,6
2,22.0,Alopecia,16261503,3
3,22.0,Impaired quality of life,16261503,6
4,22.0,Psychological trauma,16261503,6
5,22.0,Emotional distress,16261503,6
0,22.0,Alopecia,16261505,2
0,22.0,Anxiety,16261506,6
1,22.0,Impaired quality of life,16261506,6
2,22.0,Psychological trauma,16261506,6
3,22.0,Emotional distress,16261506,6
4,22.0,Pain,16261506,6
5,22.0,Alopecia,16261506,2
0,22.0,Pain,16261507,6
1,22.0,Alopecia,16261507,3
2,22.0,Emotional distress,16261507,6
3,22.0,Psychological trauma,16261507,6
4,22.0,Anxiety,16261507,6
5,22.0,Impaired quality of life,16261507,6
0,22.0,Alopecia,16261516,3
1,22.0,Psychological trauma,16261516,6
0,22.1,Pain,16261518,6
1,22.1,Impaired quality of life,16261518,6
2,22.1,Anxiety,16261518,6
3,22.1,Psychological trauma,16261518,6
4,22.1,Emotional distress,16261518,6
5,22.1,Alopecia,16261518,3
0,22.0,Alopecia,16261521,2
1,22.0,Psychological trauma,16261521,6
0,22.0,Cardiotoxicity,16261593,2
1,22.0,Troponin I increased,16261593,2
2,22.0,Oedema peripheral,16261593,2
3,22.0,Dyspnoea,16261593,2
0,22.0,Malaise,16261595,1
1,22.0,Decreased immune responsiveness,16261595,3
2,22.0,Anaemia,16261595,3
0,22.0,Pancreatitis acute,16261608,1
0,22.0,Joint effusion,16261615,6
0,22.0,Jugular vein thrombosis,16261646,6
0,22.1,Interstitial lung disease,16261668,1
0,22.0,General physical health deterioration,16261717,6
1,22.0,Off label use,16261717,6
2,22.0,Product prescribing error,16261717,6
3,22.0,Weight decreased,16261717,2
4,22.0,Decreased appetite,16261717,2
0,22.0,Cardiac failure congestive,16261739,1
1,22.0,Anaemia,16261739,1
2,22.0,Leukopenia,16261739,1
0,22.0,Acute kidney injury,16261744,1
0,22.0,Oral pain,16261916,6
1,22.0,Parathyroid disorder,16261916,1
2,22.0,Fatigue,16261916,6
3,22.0,Alopecia,16261916,6
4,22.0,Amnesia,16261916,6
5,22.0,Myalgia,16261916,6
0,22.1,Disease recurrence,16261923,6
1,22.1,Red blood cell count decreased,16261923,6
2,22.1,Back pain,16261923,2
3,22.1,Disease recurrence,16261923,2
4,22.1,Abdominal distension,16261923,6
5,22.1,Tumour marker increased,16261923,6
6,22.1,White blood cell count decreased,16261923,6
7,22.1,Anger,16261923,6
8,22.1,Dry eye,16261923,6
9,22.1,Depressed mood,16261923,6
10,22.1,Tooth abscess,16261923,2
11,22.1,Constipation,16261923,6
12,22.1,Fatigue,16261923,3
13,22.1,Vision blurred,16261923,6
14,22.1,Alopecia,16261923,6
15,22.1,Poor quality sleep,16261923,6
16,22.1,Dyspnoea,16261923,3
17,22.1,Sciatica,16261923,6
18,22.1,Neuropathy peripheral,16261923,6
19,22.1,Osteonecrosis of jaw,16261923,2
20,22.1,Neutrophil count decreased,16261923,6
21,22.1,Oedema peripheral,16261923,6
22,22.1,Dyspnoea exertional,16261923,6
23,22.1,Tooth fracture,16261923,6
0,22.1,Device related infection,16261940,1
0,22.0,Thrombocytopenia,16261948,5
1,22.0,Death,16261948,5
2,22.0,Febrile neutropenia,16261948,5
3,22.0,Sepsis,16261948,5
4,22.0,Hypovolaemic shock,16261948,5
5,22.0,Haemoptysis,16261948,5
0,22.0,Lung disorder,16261949,2
0,22.0,Mucosal inflammation,16261970,6
1,22.0,Myalgia,16261970,6
2,22.0,Bone pain,16261970,6
3,22.0,Thrombocytopenia,16261970,6
4,22.0,Multiple organ dysfunction syndrome,16261970,5
5,22.0,Blister,16261970,6
6,22.0,Hepatotoxicity,16261970,1
0,22.1,Gastric haemorrhage,16262070,1
0,22.0,Weight decreased,16262094,1
1,22.0,Anaemia,16262094,1
2,22.0,Vomiting,16262094,6
3,22.0,Pyrexia,16262094,1
4,22.0,General physical health deterioration,16262094,1
5,22.0,General physical health deterioration,16262094,3
6,22.0,Anaemia,16262094,1
0,22.0,Hyperuricaemia,16262187,2
1,22.0,Contraindicated product administered,16262187,6
0,22.0,Blood creatine phosphokinase increased,16262206,1
0,22.0,Kidney infection,16262270,6
1,22.0,Carbohydrate antigen 125 increased,16262270,1
2,22.0,Herpes zoster,16262270,6
3,22.0,Fatigue,16262270,6
4,22.0,Mass,16262270,2
5,22.0,Insomnia,16262270,6
6,22.0,Constipation,16262270,3
7,22.0,Platelet count decreased,16262270,1
8,22.0,Nausea,16262270,6
0,22.0,Breast cancer metastatic,16262279,5
0,22.0,Abdominal pain,16262291,1
1,22.0,Red blood cell count decreased,16262291,6
2,22.0,Influenza,16262291,1
3,22.0,Cholecystitis,16262291,1
4,22.0,Gallbladder necrosis,16262291,1
0,22.0,Taste disorder,16262292,3
1,22.0,Tachycardia,16262292,6
2,22.0,Product use in unapproved indication,16262292,6
3,22.0,Pneumonia,16262292,1
4,22.0,Blood phosphorus increased,16262292,3
5,22.0,Constipation,16262292,6
6,22.0,Autoimmune disorder,16262292,3
7,22.0,Thrombocytopenia,16262292,1
8,22.0,Blood glucose increased,16262292,3
9,22.0,Anaemia,16262292,6
10,22.0,Product dose omission,16262292,6
11,22.0,Dyspnoea,16262292,3
12,22.0,Nausea,16262292,2
13,22.0,Leukopenia,16262292,6
0,22.0,Nodal rhythm,16262317,1
1,22.0,Diarrhoea,16262317,1
2,22.0,Renal failure,16262317,1
0,22.1,Toxicity to various agents,16262326,6
1,22.1,Inflammation,16262326,6
2,22.1,Rash,16262326,6
3,22.1,Malignant neoplasm progression,16262326,6
4,22.1,C-reactive protein increased,16262326,6
0,22.0,Condition aggravated,16262332,6
1,22.0,Application site swelling,16262332,6
2,22.0,Off label use,16262332,1
3,22.0,Application site erythema,16262332,6
0,22.0,Pruritus,16262359,6
1,22.0,Hepatotoxicity,16262359,1
2,22.0,Haematotoxicity,16262359,2
0,22.0,Adverse event,16262365,6
1,22.0,Product use in unapproved indication,16262365,6
2,22.0,Ascites,16262365,6
3,22.0,Adverse event,16262365,6
0,22.0,Constipation,16262371,6
1,22.0,Hepatic neoplasm,16262371,6
2,22.0,Disease progression,16262371,6
3,22.0,Intestinal obstruction,16262371,6
4,22.0,Full blood count decreased,16262371,6
5,22.0,Fatigue,16262371,6
0,22.0,Oedema peripheral,16262375,2
1,22.0,Troponin I increased,16262375,2
2,22.0,Dyspnoea,16262375,2
0,22.0,Adrenal insufficiency,16262379,3
1,22.0,Malignant neoplasm progression,16262379,6
2,22.0,Pyrexia,16262379,3
3,22.0,Arthralgia,16262379,2
4,22.0,Keratitis,16262379,6
5,22.0,Oedema peripheral,16262379,3
6,22.0,Deep vein thrombosis,16262379,2
0,22.0,Leukopenia,16262408,1
1,22.0,Agranulocytosis,16262408,1
0,22.0,Agranulocytosis,16262409,1
0,22.0,Agranulocytosis,16262411,1
0,22.0,Agranulocytosis,16262412,1
1,22.0,Leukopenia,16262412,1
0,22.0,Agranulocytosis,16262415,1
0,22.0,Agranulocytosis,16262417,1
1,22.0,Leukopenia,16262417,1
0,22.0,Agranulocytosis,16262421,1
0,22.0,Leukopenia,16262422,1
1,22.0,Agranulocytosis,16262422,1
0,22.0,Leukopenia,16262431,1
1,22.0,Agranulocytosis,16262431,1
0,22.0,Leukopenia,16262432,1
1,22.0,Agranulocytosis,16262432,1
0,22.0,Leukopenia,16262436,1
1,22.0,Agranulocytosis,16262436,1
0,22.0,Agranulocytosis,16262438,1
0,22.0,Agranulocytosis,16262440,1
1,22.0,Leukopenia,16262440,1
0,22.0,Leukopenia,16262441,1
1,22.0,Agranulocytosis,16262441,1
0,22.0,Leukopenia,16262448,1
1,22.0,Agranulocytosis,16262448,1
0,22.0,Agranulocytosis,16262454,1
0,22.0,Synovial cyst,16262476,3
1,22.0,Decreased appetite,16262476,3
2,22.0,Weight decreased,16262476,3
3,22.0,Dehydration,16262476,3
4,22.0,Asthenia,16262476,6
5,22.0,Bronchitis,16262476,3
6,22.0,General physical health deterioration,16262476,3
7,22.0,Infection,16262476,3
0,22.0,Dizziness,16262596,6
1,22.0,Neoplasm progression,16262596,3
2,22.0,Decreased appetite,16262596,6
3,22.0,Drug ineffective,16262596,6
4,22.0,Asthenia,16262596,6
0,22.0,Myalgia,16262615,2
1,22.0,Muscle spasms,16262615,2
2,22.0,Muscular weakness,16262615,2
0,22.0,Off label use,16262621,6
1,22.0,Neoplasm progression,16262621,5
2,22.0,Nausea,16262621,6
0,22.0,Osteoarthritis,16262783,1
0,22.0,Drug intolerance,16262896,1
0,22.0,Death,16262989,5
0,22.0,Hydronephrosis,16263011,2
0,22.0,Death,16263015,5
0,22.0,Prostate cancer,16263029,5
0,22.1,Lacrimation increased,16263085,3
1,22.1,Pleural effusion,16263085,3
2,22.1,Headache,16263085,1
3,22.1,Leukopenia,16263085,1
4,22.1,Joint swelling,16263085,3
5,22.1,Neutropenia,16263085,1
6,22.1,Alopecia,16263085,3
7,22.1,Diarrhoea,16263085,3
8,22.1,Malignant pleural effusion,16263085,1
9,22.1,Nausea,16263085,3
0,22.0,Memory impairment,16263093,3
1,22.0,Hot flush,16263093,3
0,22.0,Death,16263095,5
0,22.0,Vomiting,16263125,6
0,22.0,Bone cancer,16263126,6
1,22.0,Osteonecrosis of jaw,16263126,2
2,22.0,Tooth extraction,16263126,6
0,22.0,Disease progression,16263151,6
0,22.0,Chills,16263154,1
1,22.0,Hypoxia,16263154,1
0,22.1,Neoplasm,16263165,6
1,22.1,Blood pressure inadequately controlled,16263165,6
2,22.1,Dizziness,16263165,6
3,22.1,Hypophysitis,16263165,6
0,22.0,Meningitis herpes,16263199,2
0,22.0,Tooth infection,16263212,1
1,22.0,Drug eruption,16263212,1
2,22.0,Neutrophil count decreased,16263212,1
0,22.0,Pain in jaw,16263224,6
1,22.0,Osteonecrosis of jaw,16263224,6
2,22.0,Prostate cancer,16263224,6
0,22.0,Bone pain,16263229,1
1,22.0,Constipation,16263229,1
2,22.0,Vomiting,16263229,1
3,22.0,Hyperhidrosis,16263229,1
4,22.0,Fatigue,16263229,1
5,22.0,Obstruction gastric,16263229,1
0,22.0,Dizziness,16263258,1
1,22.0,Malignant neoplasm progression,16263258,3
2,22.0,Lung disorder,16263258,2
0,22.0,Malignant neoplasm progression,16263313,6
1,22.0,Off label use,16263313,6
2,22.0,Product use in unapproved indication,16263313,6
0,22.0,Malignant neoplasm progression,16263364,6
1,22.0,Invasive ductal breast carcinoma,16263364,6
0,22.0,Thrombocytopenia,16263405,2
1,22.0,Anaemia,16263405,2
0,22.0,Nausea,16263414,1
1,22.0,Leukocytosis,16263414,1
0,22.0,Blood creatinine increased,16263417,6
1,22.0,Vomiting,16263417,6
2,22.0,Death,16263417,5
3,22.0,Abdominal discomfort,16263417,6
4,22.0,Blood urea increased,16263417,6
0,22.0,Off label use,16263457,5
1,22.0,Product use in unapproved indication,16263457,6
2,22.0,Death,16263457,5
0,22.0,Pleural effusion,16263463,1
0,22.0,Pain,16263491,6
1,22.0,Polyneuropathy,16263491,6
2,22.0,Death,16263491,5
0,22.0,Hypersensitivity,16263493,1
1,22.0,Pruritus,16263493,1
2,22.0,Erythema,16263493,1
3,22.0,Malaise,16263493,1
4,22.0,Pyrexia,16263493,1
0,22.0,Off label use,16263516,6
1,22.0,Intentional product use issue,16263516,6
2,22.0,Cancer pain,16263516,6
3,22.0,Neurotoxicity,16263516,2
4,22.0,Cyst,16263516,6
5,22.0,Feeling abnormal,16263516,6
6,22.0,Hepatic cyst,16263516,6
7,22.0,Pelvic fluid collection,16263516,6
0,22.0,Hypophosphataemia,16263559,2
1,22.0,Hypomagnesaemia,16263559,2
2,22.0,Hypokalaemia,16263559,2
3,22.0,Diarrhoea,16263559,1
0,22.0,Autoimmune disorder,16263569,4
0,22.0,Anaemia,16263582,1
1,22.0,Renal failure,16263582,3
0,22.0,Heart rate irregular,16263598,6
1,22.0,Thrombosis,16263598,6
0,22.0,Haemorrhage intracranial,16263603,5
0,22.0,Diabetes mellitus,16263632,2
1,22.0,Diarrhoea,16263632,2
2,22.0,Fatigue,16263632,2
3,22.0,Dehydration,16263632,1
4,22.0,Back pain,16263632,2
5,22.0,Blood urea increased,16263632,2
6,22.0,Fluid intake reduced,16263632,2
7,22.0,Musculoskeletal chest pain,16263632,1
8,22.0,Haemoglobin decreased,16263632,2
9,22.0,Dysgeusia,16263632,3
10,22.0,Nausea,16263632,1
11,22.0,Metastases to lymph nodes,16263632,6
12,22.0,Decreased appetite,16263632,2
13,22.0,White blood cell count decreased,16263632,2
14,22.0,Hypotension,16263632,2
15,22.0,Metastases to pleura,16263632,6
16,22.0,Dehydration,16263632,2
17,22.0,Nausea,16263632,2
18,22.0,Fatigue,16263632,1
19,22.0,Back pain,16263632,1
20,22.0,Blood creatinine increased,16263632,2
21,22.0,Decreased appetite,16263632,1
22,22.0,Musculoskeletal chest pain,16263632,2
0,22.0,Febrile neutropenia,16263659,6
0,22.0,Type 2 diabetes mellitus,16263661,2
0,22.0,Malaise,16263679,1
1,22.0,Fulminant type 1 diabetes mellitus,16263679,2
2,22.0,Thirst,16263679,2
0,22.0,Off label use,16263681,6
1,22.0,Death,16263681,5
2,22.0,Intentional product use issue,16263681,6
0,22.0,Death,16263697,5
0,22.0,Lower respiratory tract infection,16263730,3
0,22.0,Toxic neuropathy,16263735,1
1,22.0,Laryngospasm,16263735,1
2,22.0,Speech disorder,16263735,1
0,22.0,Transient ischaemic attack,16263737,2
0,22.0,Terminal state,16263771,6
0,22.0,Terminal state,16263779,6
1,22.0,Prostate cancer metastatic,16263779,6
0,22.0,Left ventricular dysfunction,16263788,2
1,22.0,Cardiotoxicity,16263788,2
2,22.0,Cardiac failure,16263788,2
3,22.0,Cardiomyopathy,16263788,2
0,22.0,Death,16263789,5
0,22.0,Mechanical ileus,16263792,3
0,22.0,Ulcer,16263829,1
1,22.0,Calciphylaxis,16263829,1
2,22.0,Pain,16263829,1
0,22.0,Gingival swelling,16263839,6
1,22.0,Pain in jaw,16263839,6
2,22.0,Peri-implantitis,16263839,6
3,22.0,Osteonecrosis of jaw,16263839,3
4,22.0,Gingival erythema,16263839,6
5,22.0,Mucosal hypertrophy,16263839,6
6,22.0,Jaw operation,16263839,1
0,22.0,Duodenal ulcer haemorrhage,16263863,5
0,22.0,Prostatic specific antigen increased,16263864,6
1,22.0,Euthanasia,16263864,5
2,22.0,Malignant neoplasm progression,16263864,6
3,22.0,Back pain,16263864,3
4,22.0,Drug ineffective,16263864,6
0,22.0,Confusional state,16263883,
1,22.0,Disorientation,16263883,
2,22.0,Memory impairment,16263883,
3,22.0,Feeding disorder,16263883,
4,22.0,Aphasia,16263883,
0,22.0,Transient ischaemic attack,16263889,6
0,22.0,Death,16263932,5
1,22.0,Female genital tract fistula,16263932,3
0,22.0,Intervertebral disc protrusion,16263937,3
0,22.0,Skin cancer,16263938,6
1,22.0,Malignant neoplasm progression,16263938,6
2,22.0,Drug ineffective,16263938,6
0,22.0,Hospitalisation,16263942,
1,22.0,Malaise,16263942,
0,22.0,Dyspnoea exertional,16263945,3
1,22.0,Prostatic specific antigen abnormal,16263945,3
2,22.0,Dizziness postural,16263945,6
3,22.0,Fatigue,16263945,3
4,22.0,Sleep disorder,16263945,3
5,22.0,Hot flush,16263945,3
6,22.0,Initial insomnia,16263945,3
7,22.0,Chemotherapy,16263945,6
8,22.0,Asthenia,16263945,3
9,22.0,Dizziness,16263945,3
0,22.0,Inappropriate antidiuretic hormone secretion,16263988,1
0,22.0,Neuropathy peripheral,16264004,3
1,22.0,Fatigue,16264004,3
2,22.0,Inappropriate schedule of product administration,16264004,1
0,22.0,Inguinal hernia,16264027,1
0,22.0,Decreased appetite,16264041,6
1,22.0,Gait inability,16264041,6
2,22.0,Muscle spasms,16264041,6
3,22.0,Feeling of body temperature change,16264041,6
4,22.0,Nausea,16264041,6
5,22.0,Agitation,16264041,6
6,22.0,Disorientation,16264041,6
7,22.0,Neutrophil count decreased,16264041,6
8,22.0,Fatigue,16264041,6
9,22.0,Asthenia,16264041,6
0,22.0,Post procedural infection,16264056,5
1,22.0,Fracture,16264056,6
0,22.0,Neutropenia,16264066,6
0,22.0,Product use in unapproved indication,16264068,6
1,22.0,Death,16264068,5
0,22.0,Acute kidney injury,16264070,5
1,22.0,Asthenia,16264070,6
2,22.0,Inflammatory carcinoma of breast stage IV,16264070,5
3,22.0,Dehydration,16264070,6
4,22.0,Breast cancer metastatic,16264070,5
5,22.0,Malignant neoplasm progression,16264070,5
6,22.0,Hepatic enzyme increased,16264070,6
0,22.0,Muscle contractions involuntary,16264098,1
1,22.0,Pain in extremity,16264098,1
2,22.0,Toxic neuropathy,16264098,1
3,22.0,Paraesthesia,16264098,1
0,22.0,Cholangitis sclerosing,16264105,6
0,22.0,Fatigue,16264114,6
1,22.0,Dizziness,16264114,6
2,22.0,Dyspepsia,16264114,6
3,22.0,Oesophagitis,16264114,6
0,22.0,Renal impairment,16264125,1
1,22.0,Hepatic function abnormal,16264125,1
2,22.0,Hyperthyroidism,16264125,4
3,22.0,Hypothyroidism,16264125,6
0,22.0,Pneumonia,16264129,
0,22.0,Multiple organ dysfunction syndrome,16264133,5
0,22.0,Malignant neoplasm progression,16264145,6
0,22.0,Product dose omission,16264160,6
1,22.0,No adverse event,16264160,6
2,22.0,Product availability issue,16264160,6
0,22.0,Diarrhoea,16264166,
0,22.0,Maternal exposure during pregnancy,16264174,1
1,22.0,Stillbirth,16264174,1
0,22.0,Skin exfoliation,16264258,
1,22.0,Glossodynia,16264258,
2,22.0,Stomatitis,16264258,
0,22.0,General physical health deterioration,16264280,5
1,22.0,Respiratory tract infection,16264280,5
2,22.0,Malignant neoplasm progression,16264280,5
0,22.0,Hormone-refractory prostate cancer,16264310,3
1,22.0,Metastasis,16264310,3
0,22.1,Neoplasm malignant,16264313,6
1,22.1,Arthritis,16264313,3
2,22.1,Breast cancer stage IV,16264313,6
3,22.1,Sciatica,16264313,6
4,22.1,Weight decreased,16264313,3
5,22.1,Intentional product use issue,16264313,6
0,22.0,Electrocardiogram abnormal,16264318,3
0,22.0,Neutropenia,16264323,
0,22.1,Deep vein thrombosis,16264361,2
1,22.1,Pulmonary embolism,16264361,1
2,22.1,Diarrhoea,16264361,1
3,22.1,Interstitial lung disease,16264361,2
4,22.1,Rash,16264361,2
5,22.1,Cardiac failure congestive,16264361,3
6,22.1,Hypokalaemia,16264361,1
7,22.1,Off label use,16264361,6
8,22.1,Pruritus,16264361,2
9,22.1,Enterocolitis,16264361,1
0,22.0,Colitis,16264380,1
0,22.0,Depressed level of consciousness,16264388,3
1,22.0,Asthenia,16264388,3
2,22.0,Speech disorder,16264388,3
3,22.0,Chest pain,16264388,3
0,22.0,Diarrhoea,16264392,1
0,22.0,Pain in extremity,16264434,6
0,22.0,Alopecia,16264459,6
0,22.0,Hair colour changes,16264460,3
1,22.0,Hair disorder,16264460,3
2,22.0,Madarosis,16264460,3
3,22.0,Hair texture abnormal,16264460,3
4,22.0,Alopecia,16264460,3
0,22.1,Blister,16264472,2
0,22.0,Hair texture abnormal,16264473,3
1,22.0,Hair disorder,16264473,3
2,22.0,Hair colour changes,16264473,3
3,22.0,Alopecia,16264473,3
4,22.0,Madarosis,16264473,3
0,22.1,Hair texture abnormal,16264484,3
1,22.1,Hair disorder,16264484,3
2,22.1,Hair colour changes,16264484,3
3,22.1,Alopecia,16264484,3
4,22.1,Madarosis,16264484,3
0,22.1,Hair colour changes,16264485,3
1,22.1,Madarosis,16264485,3
2,22.1,Alopecia,16264485,3
3,22.1,Hair texture abnormal,16264485,3
4,22.1,Hair disorder,16264485,3
0,22.0,Alopecia,16264488,3
1,22.0,Hair texture abnormal,16264488,3
2,22.0,Hair disorder,16264488,3
3,22.0,Madarosis,16264488,3
4,22.0,Hair colour changes,16264488,3
0,22.1,Hair texture abnormal,16264489,3
1,22.1,Madarosis,16264489,3
2,22.1,Alopecia,16264489,3
3,22.1,Hair disorder,16264489,3
4,22.1,Hair colour changes,16264489,3
0,22.0,Dupuytren^s contracture,16264519,6
0,22.0,Transient ischaemic attack,16264544,6
0,22.0,Neutropenia,16264546,6
1,22.0,Septic shock,16264546,6
0,22.0,Ileus,16264547,6
1,22.0,Vomiting,16264547,6
2,22.0,Suicidal ideation,16264547,6
3,22.0,Fatigue,16264547,6
4,22.0,Nausea,16264547,6
5,22.0,Small intestinal obstruction,16264547,1
0,22.0,Malignant neoplasm progression,16264565,6
0,22.0,Febrile neutropenia,16264574,6
1,22.0,Urinary tract infection,16264574,6
2,22.0,Asthenia,16264574,6
3,22.0,Fall,16264574,6
4,22.0,Electrolyte imbalance,16264574,6
5,22.0,Spinal fracture,16264574,6
0,22.0,Pneumonia,16264575,6
1,22.0,Neutropenic sepsis,16264575,6
0,22.0,Laryngitis,16264594,2
1,22.0,Malaise,16264594,6
0,22.1,Nail disorder,16264603,1
1,22.1,Nail ridging,16264603,1
2,22.1,Weight fluctuation,16264603,1
3,22.1,Alopecia,16264603,1
0,22.0,Alopecia,16264636,3
1,22.0,Hair colour changes,16264636,3
2,22.0,Hair texture abnormal,16264636,3
3,22.0,Hair disorder,16264636,3
4,22.0,Madarosis,16264636,3
0,22.0,Alopecia,16264641,3
0,22.0,Hair colour changes,16264651,3
1,22.0,Hair disorder,16264651,3
2,22.0,Hair texture abnormal,16264651,3
3,22.0,Madarosis,16264651,3
4,22.0,Alopecia,16264651,3
0,22.1,Alopecia,16264653,3
1,22.1,Hair texture abnormal,16264653,3
2,22.1,Hair colour changes,16264653,3
3,22.1,Hair disorder,16264653,3
0,22.1,Fatigue,16264662,6
1,22.1,White blood cell count decreased,16264662,6
2,22.1,Hot flush,16264662,6
3,22.1,Bone pain,16264662,6
4,22.1,Neoplasm progression,16264662,6
0,22.0,Alopecia,16264669,3
1,22.0,Hair texture abnormal,16264669,3
2,22.0,Hair colour changes,16264669,3
3,22.0,Hair disorder,16264669,3
0,22.0,Alopecia,16264679,3
0,22.0,Alopecia,16264684,3
1,22.0,Hair colour changes,16264684,3
2,22.0,Hair disorder,16264684,3
3,22.0,Hair texture abnormal,16264684,3
4,22.0,Madarosis,16264684,3
0,22.0,Decreased appetite,16264712,6
1,22.0,Radiation pneumonitis,16264712,2
0,22.0,Neoplasm recurrence,16264755,6
0,22.1,Pulmonary toxicity,16264785,3
1,22.1,Renal disorder,16264785,6
2,22.1,Hyponatraemia,16264785,6
3,22.1,Cardiac failure,16264785,2
4,22.1,Acute respiratory failure,16264785,6
5,22.1,Pulmonary nocardiosis,16264785,3
6,22.1,Pulmonary alveolar haemorrhage,16264785,6
7,22.1,Cardiac failure congestive,16264785,6
8,22.1,Venous thrombosis,16264785,2
0,22.0,Ascites,16264794,6
1,22.0,Colon cancer,16264794,5
2,22.0,Pain,16264794,6
3,22.0,Disease progression,16264794,6
4,22.0,Bone pain,16264794,6
0,22.0,Death,16264806,5
0,22.0,Death,16264814,5
0,22.0,Metastases to lymph nodes,16264837,6
1,22.0,Skin erosion,16264837,2
2,22.0,Haemorrhage,16264837,2
0,22.0,Malaise,16264840,6
1,22.0,Death,16264840,5
2,22.0,Product dose omission,16264840,6
0,22.0,Neoplasm progression,16264856,6
1,22.0,Oestradiol increased,16264856,1
0,22.0,Muscle spasms,16264858,6
1,22.0,Chest pain,16264858,6
2,22.0,Hypersensitivity,16264858,6
3,22.0,Skin ulcer,16264858,6
4,22.0,Stomatitis,16264858,6
5,22.0,Laboratory test abnormal,16264858,6
6,22.0,Neoplasm progression,16264858,6
7,22.0,Dysphonia,16264858,6
8,22.0,Pulmonary embolism,16264858,6
9,22.0,Infusion site urticaria,16264858,6
10,22.0,Paronychia,16264858,6
11,22.0,Neutropenia,16264858,6
12,22.0,Hypomagnesaemia,16264858,6
13,22.0,Diarrhoea,16264858,6
14,22.0,Infusion related reaction,16264858,6
15,22.0,Administration site extravasation,16264858,6
16,22.0,Hypertension,16264858,3
17,22.0,Epistaxis,16264858,6
18,22.0,Inflammation,16264858,6
19,22.0,Skin fissures,16264858,6
0,22.0,Haematotoxicity,16264860,
0,22.0,Blood test abnormal,16264872,6
0,22.0,Feeling cold,16264876,6
1,22.0,Feeling abnormal,16264876,6
2,22.0,Tremor,16264876,6
0,22.0,Drug intolerance,16264889,1
1,22.0,Neuropathy peripheral,16264889,6
2,22.0,Inappropriate schedule of product administration,16264889,6
3,22.0,Fatigue,16264889,3
0,22.0,Fatigue,16264930,3
1,22.0,Skin reaction,16264930,3
2,22.0,Nasal congestion,16264930,3
3,22.0,Hypertension,16264930,3
4,22.0,Epistaxis,16264930,3
5,22.0,Insomnia,16264930,3
6,22.0,Liver function test increased,16264930,3
7,22.0,Throat irritation,16264930,3
8,22.0,Muscle spasms,16264930,3
9,22.0,Cough,16264930,3
0,22.0,Product use in unapproved indication,16264971,6
1,22.0,Malignant neoplasm progression,16264971,6
2,22.0,Prostate cancer,16264971,6
0,22.0,Death,16264993,
0,22.1,Pyrexia,16265001,2
1,22.1,Musculoskeletal stiffness,16265001,2
2,22.1,Liver function test abnormal,16265001,3
0,22.0,Hepatic enzyme increased,16265004,1
1,22.0,Breast cancer,16265004,3
2,22.0,Malignant neoplasm progression,16265004,3
0,22.0,Hypothyroidism,16265022,3
1,22.0,Proteinuria,16265022,2
2,22.0,Diarrhoea,16265022,3
3,22.0,Renal cancer metastatic,16265022,5
4,22.0,Achromotrichia acquired,16265022,3
5,22.0,Gamma-glutamyltransferase abnormal,16265022,2
6,22.0,Hypertension,16265022,1
7,22.0,Dysgeusia,16265022,1
8,22.0,Malignant neoplasm progression,16265022,5
9,22.0,Asthenia,16265022,3
0,22.0,Death,16265030,5
0,22.0,Fulminant type 1 diabetes mellitus,16265037,6
0,22.0,Death,16265055,5
0,22.1,Myocarditis,16265070,5
0,22.0,Blood creatinine increased,16265091,6
0,22.0,Death,16265099,5
0,22.0,Renal disorder,16265194,6
1,22.0,Off label use,16265194,6
0,22.1,Death,16265206,5
1,22.1,Rash,16265206,6
2,22.1,Renal failure,16265206,6
0,22.1,Syncope,16265213,2
1,22.1,Weight decreased,16265213,6
2,22.1,Circulatory collapse,16265213,1
3,22.1,Lacrimation increased,16265213,3
4,22.1,Constipation,16265213,2
5,22.1,Abdominal pain lower,16265213,2
0,22.0,Death,16265216,5
1,22.0,Product use issue,16265216,6
0,22.0,Device related infection,16265224,
0,22.0,Overdose,16265226,1
0,22.1,Embolism,16265274,2
1,22.1,Hyperglycaemia,16265274,3
0,22.0,Metastases to liver,16265320,
1,22.0,Metastasis,16265320,
2,22.0,Off label use,16265320,
3,22.0,Fall,16265320,
0,22.0,Death,16265337,
0,22.1,Nausea,16265346,6
1,22.1,Pain,16265346,6
2,22.1,Back pain,16265346,6
3,22.1,Abdominal pain,16265346,6
4,22.1,Blood creatinine increased,16265346,6
5,22.1,Painful respiration,16265346,6
6,22.1,Hyponatraemia,16265346,6
7,22.1,Speech disorder,16265346,6
8,22.1,Pyrexia,16265346,6
0,22.0,Hair disorder,16265355,3
1,22.0,Alopecia,16265355,6
2,22.0,Hair colour changes,16265355,3
3,22.0,Hair texture abnormal,16265355,3
4,22.0,Madarosis,16265355,3
0,22.0,Orchitis,16265545,6
0,22.0,Interstitial lung disease,16265552,1
1,22.0,Glycosylated haemoglobin increased,16265552,3
2,22.0,Blood thyroid stimulating hormone increased,16265552,3
0,22.0,Radiation pneumonitis,16265591,3
0,22.1,Atrial fibrillation,16265695,2
1,22.1,Taste disorder,16265695,6
2,22.1,Nausea,16265695,6
3,22.1,Fatigue,16265695,2
4,22.1,Tumour marker increased,16265695,6
5,22.1,Abdominal pain,16265695,6
6,22.1,Decreased appetite,16265695,3
7,22.1,Alopecia,16265695,6
8,22.1,Blood count abnormal,16265695,1
9,22.1,Anaemia,16265695,2
10,22.1,Weight increased,16265695,6
11,22.1,Peripheral swelling,16265695,6
12,22.1,Dyspnoea,16265695,6
13,22.1,Blood iron decreased,16265695,6
14,22.1,Malignant neoplasm progression,16265695,6
0,22.0,Product lot number issue,16265718,6
1,22.0,Fall,16265718,3
2,22.0,Asthenia,16265718,3
0,22.0,Condition aggravated,16265723,6
1,22.0,Pneumonia bacterial,16265723,2
0,22.0,Pyelonephritis,16265754,6
0,22.1,Ejection fraction decreased,16265755,2
1,22.1,Cardiac failure congestive,16265755,3
0,22.0,Adenocarcinoma of colon,16265761,6
1,22.0,Intracranial haemangioma,16265761,6
2,22.0,Central nervous system lesion,16265761,6
3,22.0,Carbohydrate antigen 19-9,16265761,6
4,22.0,Carcinoembryonic antigen increased,16265761,6
5,22.0,Seizure,16265761,6
6,22.0,Off label use,16265761,6
0,22.0,Agranulocytosis,16265787,1
0,22.0,Agranulocytosis,16265789,1
0,22.0,Drug intolerance,16265801,2
1,22.0,Cardiac failure congestive,16265801,2
0,22.0,Anaemia,16265805,1
1,22.0,Proctalgia,16265805,1
2,22.0,Dehydration,16265805,1
3,22.0,Urinary tract infection,16265805,1
4,22.0,Fatigue,16265805,1
5,22.0,Staphylococcal infection,16265805,1
6,22.0,Diarrhoea,16265805,1
7,22.0,Leukopenia,16265805,1
0,22.0,Lung disorder,16265835,2
0,22.0,Product dose omission,16265842,6
1,22.0,No adverse event,16265842,6
2,22.0,Product availability issue,16265842,6
0,22.0,Malignant neoplasm progression,16265899,6
1,22.0,Small cell lung cancer,16265899,2
0,22.0,Hypertension,16265901,6
1,22.0,Insomnia,16265901,6
2,22.0,Eye irritation,16265901,6
3,22.0,Stress,16265901,6
4,22.0,Faeces soft,16265901,6
0,22.0,Neoplasm malignant,16265998,3
0,22.0,Fall,16266002,6
1,22.0,Fracture,16266002,3
0,22.0,Liver disorder,16266003,3
0,22.0,Sepsis,16266004,1
0,22.0,Cardiac failure,16266005,1
0,22.0,Skin necrosis,16266018,1
1,22.0,Skin ulcer,16266018,1
0,22.0,Product use issue,16266027,6
1,22.0,Off label use,16266027,6
2,22.0,Full blood count decreased,16266027,2
0,22.0,Neutropenia,16266035,2
1,22.0,Liver injury,16266035,2
0,22.0,White blood cell count decreased,16266077,6
1,22.0,Food poisoning,16266077,6
2,22.0,Product dose omission,16266077,6
3,22.0,Haemoglobin decreased,16266077,6
0,22.0,Device dislocation,16266127,1
1,22.0,Cystitis,16266127,1
2,22.0,Spinal column injury,16266127,1
3,22.0,Ligament rupture,16266127,1
4,22.0,Dysphagia,16266127,1
5,22.0,Polyneuropathy,16266127,3
6,22.0,Nasopharyngitis,16266127,1
0,22.0,Throat irritation,16266132,1
0,22.0,Coma,16266200,3
1,22.0,Death,16266200,5
2,22.0,Off label use,16266200,
0,22.1,Drug-device incompatibility,16266220,6
1,22.1,Infusion related reaction,16266220,1
2,22.1,Vascular device infection,16266220,5
0,22.0,Interstitial lung disease,16266221,1
1,22.0,Blood thyroid stimulating hormone increased,16266221,3
2,22.0,Diabetes mellitus,16266221,3
0,22.0,White blood cell count increased,16266241,
1,22.0,Stomatitis,16266241,3
2,22.0,Off label use,16266241,
3,22.0,Dry skin,16266241,3
4,22.0,Dysphonia,16266241,3
5,22.0,Back pain,16266241,
6,22.0,Neuropathy peripheral,16266241,3
7,22.0,Hepatic enzyme increased,16266241,3
8,22.0,Fatigue,16266241,3
9,22.0,Decreased appetite,16266241,3
0,22.0,Febrile neutropenia,16266244,1
0,22.1,Diarrhoea,16266276,2
1,22.1,Urinary tract infection,16266276,6
2,22.1,Musculoskeletal pain,16266276,6
3,22.1,Pain in extremity,16266276,6
4,22.1,Fall,16266276,2
5,22.1,Lethargy,16266276,3
6,22.1,Hypotension,16266276,3
7,22.1,Fatigue,16266276,3
8,22.1,Gait inability,16266276,3
9,22.1,Dysphonia,16266276,3
10,22.1,Stubbornness,16266276,3
11,22.1,Bowel movement irregularity,16266276,6
12,22.1,Decreased appetite,16266276,2
13,22.1,Confusional state,16266276,2
14,22.1,Asthenia,16266276,2
15,22.1,Chest pain,16266276,6
16,22.1,Sluggishness,16266276,3
17,22.1,Dehydration,16266276,2
18,22.1,Nausea,16266276,2
19,22.1,Vomiting,16266276,2
20,22.1,Headache,16266276,3
21,22.1,Blood pressure systolic increased,16266276,3
22,22.1,Insomnia,16266276,3
23,22.1,Back pain,16266276,6
24,22.1,Decubitus ulcer,16266276,6
0,22.0,Cardiac failure,16266332,5
1,22.0,Peripheral swelling,16266332,5
2,22.0,Hypotension,16266332,5
3,22.0,Cardiac failure,16266332,6
4,22.0,Dyspnoea,16266332,5
0,22.0,Acute hepatic failure,16266338,6
0,22.0,Off label use,16266371,6
1,22.0,Gastrointestinal toxicity,16266371,2
2,22.0,Electrolyte imbalance,16266371,2
0,22.0,Hepatotoxicity,16266399,6
1,22.0,Gastrointestinal toxicity,16266399,6
0,22.0,Dyspnoea,16266409,1
1,22.0,Pruritus,16266409,1
2,22.0,Oedema,16266409,1
3,22.0,Erythema,16266409,1
0,22.0,Cerebrovascular accident,16266437,3
1,22.0,Musculoskeletal stiffness,16266437,3
2,22.0,Fall,16266437,3
3,22.0,Contusion,16266437,3
0,22.0,Metastases to lung,16266455,5
1,22.0,Metastases to pleura,16266455,6
0,22.0,Diarrhoea,16266578,1
1,22.0,Malaise,16266578,1
2,22.0,Fatigue,16266578,1
0,22.0,Pyrexia,16266579,6
1,22.0,Headache,16266579,3
2,22.0,Hypersensitivity,16266579,6
3,22.0,Choking sensation,16266579,3
4,22.0,Cough,16266579,6
5,22.0,Dizziness,16266579,3
6,22.0,Asthma,16266579,6
7,22.0,Inappropriate schedule of product administration,16266579,6
8,22.0,Choking,16266579,6
9,22.0,Urticaria,16266579,3
10,22.0,Bone pain,16266579,6
11,22.0,Vomiting,16266579,3
12,22.0,Dyspnoea,16266579,3
0,22.0,Dyspnoea,16266585,6
1,22.0,Epistaxis,16266585,6
2,22.0,Pneumonitis,16266585,6
3,22.0,Fatigue,16266585,6
0,22.0,Malignant neoplasm progression,16266659,6
0,22.1,Fatigue,16266682,3
1,22.1,Blood count abnormal,16266682,6
2,22.1,Pruritus,16266682,3
3,22.1,Headache,16266682,6
4,22.1,Dry mouth,16266682,6
5,22.1,Hot flush,16266682,3
0,22.0,Psychological trauma,16266690,6
1,22.0,Alopecia,16266690,2
2,22.0,Emotional distress,16266690,6
0,22.0,Alopecia,16266697,2
1,22.0,Psychological trauma,16266697,6
0,22.0,Psychological trauma,16266698,6
1,22.0,Anxiety,16266698,6
2,22.0,Pain,16266698,6
3,22.0,Impaired quality of life,16266698,6
4,22.0,Alopecia,16266698,2
5,22.0,Emotional distress,16266698,6
0,22.0,Headache,16266699,6
1,22.0,Pain,16266699,6
2,22.0,Sinus headache,16266699,3
3,22.0,Weight decreased,16266699,3
4,22.0,Taste disorder,16266699,3
5,22.0,Dyspepsia,16266699,3
6,22.0,Migraine,16266699,6
7,22.0,Neuropathy peripheral,16266699,4
8,22.0,Nerve compression,16266699,6
9,22.0,Parosmia,16266699,3
0,22.1,Prerenal failure,16266728,1
1,22.1,Intentional product use issue,16266728,6
0,22.0,General physical health deterioration,16266735,5
1,22.0,Dyspnoea,16266735,5
2,22.0,Vomiting,16266735,5
3,22.0,Interstitial lung disease,16266735,5
4,22.0,Panic attack,16266735,5
5,22.0,Discomfort,16266735,5
6,22.0,Anxiety,16266735,5
7,22.0,Depressed mood,16266735,5
8,22.0,Nausea,16266735,5
9,22.0,Cough,16266735,5
10,22.0,Leukopenia,16266735,5
11,22.0,Metastases to lung,16266735,6
12,22.0,Pain,16266735,5
13,22.0,Chest discomfort,16266735,5
14,22.0,Thrombocytopenia,16266735,6
0,22.0,Cardio-respiratory arrest,16266736,5
1,22.0,Blood urea increased,16266736,6
0,22.0,Death,16266742,5
1,22.0,Product use in unapproved indication,16266742,6
0,22.0,Hypertension,16266748,6
1,22.0,Decreased appetite,16266748,6
2,22.0,Liver disorder,16266748,6
0,22.0,Hypophosphataemia,16266749,6
0,22.0,Cardiomyopathy,16266822,6
0,22.0,Pneumonitis,16266850,1
0,22.0,Polyarthritis,16267077,3
1,22.0,Malignant neoplasm progression,16267077,3
0,22.0,Acute kidney injury,16267088,1
0,22.0,Product use in unapproved indication,16267120,6
0,22.0,Pneumonitis,16267157,5
0,22.0,Acute myeloid leukaemia,16267164,3
1,22.0,Platelet count decreased,16267164,6
2,22.0,Myelodysplastic syndrome,16267164,3
0,22.0,Blood calcium decreased,16267167,6
1,22.0,Rash,16267167,6
0,22.0,Anaemia,16267170,1
0,22.1,Scan abnormal,16267185,6
1,22.1,Vomiting,16267185,6
2,22.1,Anxiety,16267185,1
3,22.1,Neuropathy peripheral,16267185,1
4,22.1,Chest pain,16267185,1
5,22.1,Abdominal pain,16267185,3
6,22.1,Constipation,16267185,1
7,22.1,Anaemia,16267185,3
8,22.1,Blister,16267185,6
9,22.1,Photosensitivity reaction,16267185,3
10,22.1,Nausea,16267185,3
11,22.1,Confusional state,16267185,6
12,22.1,Gastrooesophageal reflux disease,16267185,2
13,22.1,Blood pressure abnormal,16267185,6
14,22.1,Fatigue,16267185,2
15,22.1,Hypertension,16267185,3
16,22.1,Headache,16267185,6
0,22.0,Pain,16267222,6
1,22.0,Prostate cancer stage IV,16267222,6
2,22.0,Product use in unapproved indication,16267222,6
3,22.0,Malignant neoplasm progression,16267222,6
0,22.0,Asthenia,16267228,1
0,22.0,Intracardiac thrombus,16267234,6
1,22.0,Acute pulmonary oedema,16267234,6
2,22.0,Paralysis,16267234,6
3,22.0,Disorientation,16267234,6
4,22.0,Dyspraxia,16267234,6
5,22.0,Constipation,16267234,6
6,22.0,Bundle branch block left,16267234,6
7,22.0,Cerebrovascular accident,16267234,4
8,22.0,Cytotoxic cardiomyopathy,16267234,6
9,22.0,Hemiplegia,16267234,6
10,22.0,Skin abrasion,16267234,6
11,22.0,Paresis,16267234,4
12,22.0,Visual acuity reduced,16267234,6
13,22.0,Language disorder,16267234,2
14,22.0,Muscle spasticity,16267234,6
15,22.0,Stereotypy,16267234,6
16,22.0,Headache,16267234,6
17,22.0,Mutism,16267234,6
18,22.0,Anal incontinence,16267234,6
19,22.0,Speech disorder,16267234,6
20,22.0,Cerebral disorder,16267234,6
21,22.0,Complication associated with device,16267234,6
22,22.0,Reading disorder,16267234,6
23,22.0,Learning disorder,16267234,6
24,22.0,Ejection fraction decreased,16267234,6
25,22.0,Facial paralysis,16267234,6
26,22.0,Atrial fibrillation,16267234,6
27,22.0,Intracranial haematoma,16267234,6
28,22.0,Periarthritis,16267234,6
29,22.0,Aphasia,16267234,6
30,22.0,Memory impairment,16267234,6
31,22.0,Communication disorder,16267234,6
32,22.0,Attention deficit/hyperactivity disorder,16267234,6
33,22.0,Gait disturbance,16267234,2
34,22.0,Movement disorder,16267234,2
35,22.0,Alexia,16267234,6
0,22.0,Malignant neoplasm progression,16267261,6
1,22.0,Pneumonia,16267261,6
2,22.0,Dehydration,16267261,6
3,22.0,Breast cancer female,16267261,6
4,22.0,Drug ineffective,16267261,6
0,22.0,Death,16267262,5
0,22.0,Malignant neoplasm progression,16267263,5
1,22.0,Non-small cell lung cancer,16267263,5
0,22.0,Off label use,16267310,6
1,22.0,Disease progression,16267310,6
0,22.0,Cataract,16267313,1
0,22.0,Agranulocytosis,16267331,1
0,22.0,Agranulocytosis,16267333,1
0,22.1,Cognitive disorder,16267336,3
0,22.0,Agranulocytosis,16267339,1
0,22.0,Erythema,16267447,1
1,22.0,Dyspnoea,16267447,1
2,22.0,Blood pressure increased,16267447,1
0,22.1,Sepsis,16267460,6
1,22.1,Thrombocytopenia,16267460,1
2,22.1,Herpes zoster,16267460,1
3,22.1,Cerebral haemorrhage,16267460,2
4,22.1,Plasma cell myeloma,16267460,6
5,22.1,Colon cancer stage IV,16267460,6
0,22.0,Rash,16267464,3
0,22.0,Death,16267479,5
1,22.0,Intentional product use issue,16267479,6
0,22.0,Neutropenia,16267499,2
1,22.0,Liver injury,16267499,2
0,22.0,Stevens-Johnson syndrome,16267533,6
0,22.0,Dyspnoea,16267567,1
0,22.0,Junctional ectopic tachycardia,16267619,1
0,22.0,Off label use,16267637,6
1,22.0,Death,16267637,5
2,22.0,Intentional product use issue,16267637,6
0,22.0,Loss of consciousness,16267668,1
1,22.0,Shock,16267668,1
2,22.0,Blood pressure immeasurable,16267668,1
3,22.0,Pallor,16267668,1
4,22.0,Hyperhidrosis,16267668,1
5,22.0,Dyspnoea,16267668,1
0,22.0,Malignant neoplasm progression,16267673,6
0,22.0,Proteinuria,16267710,6
1,22.0,Azotaemia,16267710,6
2,22.0,Hypertension,16267710,6
3,22.0,Thrombocytopenia,16267710,6
0,22.0,Death,16267721,5
0,22.0,Malignant neoplasm progression,16267726,6
1,22.0,Interstitial lung disease,16267726,3
0,22.0,Hot flush,16267734,6
1,22.0,Myalgia,16267734,6
2,22.0,Diarrhoea,16267734,6
3,22.0,Fatigue,16267734,6
0,22.0,Drug intolerance,16267774,6
1,22.0,Pneumonitis,16267774,6
0,22.0,Death,16267924,5
0,22.0,Thrombophlebitis,16267935,1
0,22.0,Antiphospholipid syndrome,16267936,1
0,22.0,Body temperature abnormal,16268207,3
1,22.0,Chills,16268207,3
2,22.0,Fatigue,16268207,3
3,22.0,Raynaud^s phenomenon,16268207,3
4,22.0,Feeling cold,16268207,3
0,22.0,Osteonecrosis of jaw,16268269,3
1,22.0,Secretion discharge,16268269,3
2,22.0,Impaired healing,16268269,3
3,22.0,Sequestrectomy,16268269,2
0,22.0,Product use in unapproved indication,16268297,6
1,22.0,Adverse event,16268297,6
0,22.0,Colitis,16268329,1
1,22.0,Pyrexia,16268329,1
2,22.0,Diarrhoea,16268329,1
3,22.0,Skin disorder,16268329,2
4,22.0,Nausea,16268329,1
0,22.0,Death,16268352,5
0,22.0,Death,16268353,5
0,22.0,Intestinal perforation,16268354,4
0,22.0,Hypertension,16268420,3
1,22.0,Anaemia,16268420,3
2,22.0,Palmar-plantar erythrodysaesthesia syndrome,16268420,3
3,22.0,Haemorrhage,16268420,3
4,22.0,Cough,16268420,2
5,22.0,Vision blurred,16268420,3
